» Articles » PMID: 31163980

Mortality From Ischemic Heart Disease

Overview
Date 2019 Jun 6
PMID 31163980
Citations 328
Authors
Affiliations
Soon will be listed here.
Abstract

Background Ischemic heart disease (IHD) has been considered the top cause of mortality globally. However, countries differ in their rates and there have been changes over time. Methods and Results We analyzed mortality data submitted to the World Health Organization from 2005 to 2015 by individual countries. We explored patterns in relationships with age, sex, and income and calculated age-standardized mortality rates for each country in addition to crude death rates. In 5 illustrative countries which provided detailed data, we analyzed trends of mortality from IHD and 3 noncommunicable diseases (lung cancer, stroke, and chronic lower respiratory tract diseases) and examined the simultaneous trends in important cardiovascular risk factors. Russia, United States, and Ukraine had the largest absolute numbers of deaths among the countries that provided data. Among 5 illustrative countries (United Kingdom, United States, Brazil, Kazakhstan, and Ukraine), IHD was the top cause of death, but mortality from IHD has progressively decreased from 2005 to 2015. Age-standardized IHD mortality rates per 100 000 people per year were much higher in Ukraine (324) and Kazakhstan (97) than in United States (60), Brazil (54), and the United Kingdom (46), with much less difference in other causes of death. All 5 countries showed a progressive decline in IHD mortality, with a decline in smoking and hypertension and in all cases a rise in obesity and type II diabetes mellitus. Conclusions IHD remains the single largest cause of death in countries of all income groups. Rates are different between countries and are falling in most countries, indicating great potential for further gains. On the horizon, future improvements may become curtailed by increasing hypertension in some developing countries and more importantly global growth in obesity.

Citing Articles

Global, regional, and national epidemiology of ischemic heart disease among individuals aged 55 and above from 1990 to 2021: a cross-sectional study.

Xue P, Lin L, Li P, Cheng S, Chen D, Fan M BMC Public Health. 2025; 25(1):985.

PMID: 40075403 PMC: 11905664. DOI: 10.1186/s12889-025-22193-6.


Assessment of the prognostic performance of TIMI, PAMI, CADILLAC and GRACE scores for short-term major adverse cardiovascular events in patients undergoing emergent percutaneous revascularisation: a prospective observational study.

Kumar R, Safdar U, Yaqoob N, Khan S, Matani K, Khan N BMJ Open. 2025; 15(3):e091028.

PMID: 40074268 PMC: 11904351. DOI: 10.1136/bmjopen-2024-091028.


Associations of patient knowledge with drug-modifiable cardiovascular risk factor control in coronary artery disease patients with and without diabetes mellitus: results from the cross-sectional KNOW-ABC study.

Brockmeyer M, Fell M, Parco C, Hoss A, Vargas K, Wies E BMC Cardiovasc Disord. 2025; 25(1):148.

PMID: 40045198 PMC: 11881313. DOI: 10.1186/s12872-025-04599-7.


Trends and regional variations in chronic ischemic heart disease and lung cancer-related mortality among American adults: Insights from retrospective CDC wonder analysis.

Ali E, Rahman H, Kamal U, Ali Fahim M, Salman M, Salman A Int J Cardiol Cardiovasc Risk Prev. 2025; 24:200377.

PMID: 40034236 PMC: 11875809. DOI: 10.1016/j.ijcrp.2025.200377.


Ten-year atherosclerotic cardiovascular disease risk score in post-menopausal women with low bone mineral density.

Wani K, Sabico S, Veronese N, Al-Masri A, Al-Daghri N Aging Clin Exp Res. 2025; 37(1):56.

PMID: 40011291 PMC: 11865107. DOI: 10.1007/s40520-025-02957-1.


References
1.
Wakefield M, Loken B, Hornik R . Use of mass media campaigns to change health behaviour. Lancet. 2010; 376(9748):1261-71. PMC: 4248563. DOI: 10.1016/S0140-6736(10)60809-4. View

2.
. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet. 2011; 43(4):339-44. DOI: 10.1038/ng.782. View

3.
Roberts B, Stickley A, Balabanova D, Haerpfer C, Mckee M . The persistence of irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health. 2012; 66(11):1079-82. DOI: 10.1136/jech-2011-200645. View

4.
Kulkayeva G, Harun-Or-Rashid M, Yoshida Y, Tulebayev K, Sakamoto J . Cardiovascular disease risk factors among rural Kazakh population. Nagoya J Med Sci. 2012; 74(1-2):51-61. PMC: 4831250. View

5.
Finegold J, Asaria P, Francis D . Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2012; 168(2):934-45. PMC: 3819990. DOI: 10.1016/j.ijcard.2012.10.046. View